Abstract
We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Font-Creus B., Bella-Cueto F., Espejo-Arenas E., Vidal-Sanahuja R., Muñoz-Espin T., Nolla-Salas M., Casagran-Borrell A., Mercade-Cuesta J., Segura-Porta F. Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis. 1985 Sep-Oct;7(5):635–642. doi: 10.1093/clinids/7.5.635. [DOI] [PubMed] [Google Scholar]
- Höffken G., Lode H., Prinzing C., Borner K., Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother. 1985 Mar;27(3):375–379. doi: 10.1128/aac.27.3.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raoult D., Gallais H., Ottomani A., Resch J. P., Tichadou D., De Micco P., Casanova P. La forme maligne de la fièvre boutonneuse méditerranéenne. Six observations. Presse Med. 1983 Oct 29;12(38):2375–2378. [PubMed] [Google Scholar]
- Raoult D., Roussellier P., Galicher V., Perez R., Tamalet J. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother. 1986 Mar;29(3):424–425. doi: 10.1128/aac.29.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raoult D., Weiller P. J., Chagnon A., Chaudet H., Gallais H., Casanova P. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg. 1986 Jul;35(4):845–850. doi: 10.4269/ajtmh.1986.35.845. [DOI] [PubMed] [Google Scholar]